Prolensa wins on every point. Safer, cleaner, not snotty, no shaking, equal anti-inflammation data, and way more drops per bottle. If we do not have all Tier 1-2 coverage of Med D then Ilevro is going to be a total failure and Nevenac is going to lose massive market share. Just being honest. Our other advantage is that the BL reps out West are morons.